NCT04255849 2026-01-23
Nine-valent HPV Vaccine to Prevent Persistent Oral HPV Infection in Men Living With HIV
Weill Medical College of Cornell University
Phase 3 Active not recruiting
Clinical Trials
10 trialsNCT06632912 2026-01-23
Phase IIIb Clinical Trial of Quadrivalent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) for Age/Immunization Schedule Bridging
National Vaccine and Serum Institute, China
Phase 3 Active not recruiting
NCT04708041 2025-04-20
V503-069
Merck Sharp & Dohme LLC
Phase 3 Active not recruiting
NCT04199689 2025-03-25
V503-049
Merck Sharp & Dohme LLC
Phase 3 Active not recruiting
NCT05285826 2024-12-16
Efficacy, Immunogenicity, and Safety of V503 in Chinese Males (V503-052)
Merck Sharp & Dohme LLC
Phase 3 Active not recruiting
NCT04794660 2024-03-13
CESTA
International Agency for Research on Cancer
Phase 3 Active not recruiting
NCT06041061 2023-09-18
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of SCT1000 in Healthy Women Aged 18-45 Years
Sinocelltech Ltd.
Phase 3 Active not recruiting
NCT05662020 2022-12-27
A Study to Evaluate the Immunogenicity and Safety of HPV Vaccine in Healthy Female Participants Aged 9-26 Years in China
Beijing Health Guard Biotechnology, Inc
Phase 3 Active not recruiting
NCT03998254 2022-11-16
V503-023
Merck Sharp & Dohme LLC
Phase 3 Active not recruiting
NCT05450705 2022-09-02
V503-071
Merck Sharp & Dohme LLC
Phase 3 Active not recruiting